Ernexa Therapeutics ERNA Q3 2023 Earnings Net loss of 103 per share highlights ongoing clinical investment stock declines 377 OLED Q1 2026 Earnings EPS Misses Estimates by Wide Margin But Stock Climbs NEGG Q4 2022 Earnings Sharp EPS Miss Overshadows Modest Stock Uptick ASIX Q1 2026 Earnings Miss on EPS Stock Rises Despite Weakness EFSCP Q1 2026 Earnings EPS Misses Estimates Shares Edge Lower Rayonier Inc REIT RYN Q1 2026 Earnings Massive EPS Beat Defies Expectations